Bariatric Surgery plays a large role in treating Type 2 Diabetes at Griffin Hospital
Two randomized clinical trials published this week in The New England Journal of Medicine demonstrate bariatric surgery is the most effective treatment for type 2 diabetes in obese and morbidly obese patients and suggest surgery should be considered sooner and more often for patients battling the twin epidemics of diabetes and obesity. The results for the first head-to-head trials comparing surgery to medical treatment were: • In the study conducted by the Cleveland Clinic, patients were studied who had a Body Mass Index (BMI) between 27 and 43. Within one year, diabetes remission rates with bariatric surgery were about 40 percent (42% with the gastric bypass, 37% with the sleeve gastrectomy) compared to about 12 percent for patients treated with the best medical therapy available. • In the two-year study conducted by Catholic University of Rome Italy and New York-Presbyterian/Weill Cornell Medical Center, remission rates were about 85 percent for bariatric surgery (75% with the gastric bypass, 95% with the biliopancreatic diversion) and zero for medical therapy in patients with BMI greater than 35. • In the surgical groups, both... Read More